U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147257) titled 'A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA(R) (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions' on Aug. 12.
Brief Summary: A Single-Center, Randomized, Single-Blind, Single-Dose, Parallel-Group Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA(R) (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants under Fasting Conditions
Study Start Date: Feb. 12
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
BIOLOGICAL: CHS-1420
Dose of 40 mg will be subcutaneously administered to...